共 99 条
[1]
Untch M(2014)Current and future role of neoadjuvant therapy for breast cancer Breast 23 526-537
[2]
Konecny GE(2014)Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 384 164-172
[3]
Paepker S(2015)Pathological complete response in neoadjuvant treatment of breast cancer Ann Surg Oncol 22 1441-1446
[4]
von Minckwitz P(2014)Neoadjuvant therapy in the treatment of breast cancer Surg Oncol Clin N Am 23 505-523
[5]
Cortazar L(2013)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy Eur J Nucl Med Mol Imaging 40 1809-1816
[6]
Zhang M(2015)F-FDG PET/CT to predict response to neoadjuvant chemotherapy and prognosis in inflammatory breast cancer J Nucl Med 56 1315-1321
[7]
Untch K(2012)Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course Breast Cancer Res Treat 131 517-525
[8]
Mehta JP(2014)The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy Eur J Nucl Med Mol Imaging 41 1852-1860
[9]
Costantino N(2017)FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis Breast Cancer Res 19 3-542
[10]
Wolmark P(2015)[(18)F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study Ann Nucl Med 29 535-294